Premier Biomedical, Inc. is a research-based firm that develops cures for Amyotrophic Lateral Sclerosis (ALS), Traumatic Brain Injury (TBI), Multiple Sclerosis (MS), Clinical Depression, Alzheimer’s Disease, Blood Sepsis, Atherosclerosis, and Cancer.
|HQ||Jackson Center, US|
Revenue (Q2, 2018)
Gross profit (Q2, 2018)
Gross profit margin (Q2, 2018), %
Net income (Q2, 2018)
Market capitalization (8-Oct-2018)
Premier Biomedical has 170 Twitter Followers. The number of followers has decreased 2.1% month over month and decreased 2.8% quarter over quarter